Envista Holdings Return on Investment 2018-2025 | NVST
Envista Holdings ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2025-03-31 | $-1.05B | $4.33B | -24.22% |
2024-12-31 | $-1.04B | $4.21B | -22.46% |
2024-09-30 | $-1.29B | $4.38B | -25.94% |
2024-06-30 | $-1.23B | $4.37B | -23.18% |
2024-03-31 | $0.01B | $5.53B | 0.13% |
2023-12-31 | $0.03B | $5.57B | 0.57% |
2023-09-30 | $0.32B | $5.67B | 6.11% |
2023-06-30 | $0.31B | $5.19B | 6.21% |
2023-03-31 | $0.30B | $5.15B | 6.02% |
2022-12-31 | $0.32B | $5.08B | 6.51% |
2022-09-30 | $0.28B | $4.81B | 5.69% |
2022-06-30 | $0.29B | $4.88B | 5.83% |
2022-03-31 | $0.30B | $4.91B | 6.23% |
2021-12-31 | $0.31B | $4.94B | 6.38% |
2021-09-30 | $0.38B | $4.84B | 7.95% |
2021-06-30 | $0.36B | $4.76B | 7.34% |
2021-03-31 | $0.16B | $4.64B | 3.31% |
2020-12-31 | $0.04B | $4.63B | 0.87% |
2020-09-30 | $-0.04B | $5.32B | -0.69% |
2020-06-30 | $-0.02B | $5.22B | -0.36% |
2020-03-31 | $0.17B | $5.03B | 4.51% |
2019-12-31 | $0.24B | $4.86B | 9.75% |
2019-06-30 | $0.20B | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $3.334B | $2.511B |
Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
Boston Scientific (BSX) | United States | $153.611B | 38.46 |
Stryker (SYK) | United States | $149.817B | 31.33 |
EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
Medtronic (MDT) | Ireland | $112.441B | 15.94 |
Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
ResMed (RMD) | United States | $37.597B | 28.24 |
GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
Agilent Technologies (A) | United States | $33.875B | 22.08 |
Terumo (TRUMY) | Japan | $24.770B | 32.17 |
Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
Insulet (PODD) | United States | $21.162B | 83.07 |
Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
Baxter (BAX) | United States | $15.236B | 11.38 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
Demant (WILYY) | Denmark | $8.971B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
Haemonetics (HAE) | United States | $3.609B | 16.44 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.192B | 23.54 |
QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
AtriCure (ATRC) | United States | $1.561B | 0.00 |
Acuren (TIC) | United States | $1.375B | 0.00 |
AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
Neogen (NEOG) | United States | $1.081B | 13.83 |
BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
InMode (INMD) | Israel | $0.954B | 9.62 |
Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
Owens & Minor (OMI) | United States | $0.669B | 5.55 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
CeriBell (CBLL) | United States | $0.622B | 0.00 |
Evolus (EOLS) | United States | $0.589B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
Valneva SE (VALN) | France | $0.488B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
Surmodics (SRDX) | United States | $0.424B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
SNDL (SNDL) | Canada | $0.326B | 0.00 |
Quanterix (QTRX) | United States | $0.315B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
Cerus (CERS) | United States | $0.277B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
ZimVie (ZIMV) | United States | $0.263B | 11.94 |
Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
Brainsway (BWAY) | Israel | $0.253B | 66.85 |
Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
Biote (BTMD) | United States | $0.218B | 6.14 |
TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
High Tide (HITI) | Canada | $0.188B | 0.00 |
Organigram Global (OGI) | Canada | $0.186B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
Omeros (OMER) | United States | $0.180B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
Exagen (XGN) | United States | $0.148B | 0.00 |
Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
Apyx Medical (APYX) | United States | $0.098B | 0.00 |
Fonar (FONR) | United States | $0.096B | 12.37 |
Jin Medical (ZJYL) | China | $0.090B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
MacroGenics (MGNX) | United States | $0.086B | 0.00 |
Veru (VERU) | United States | $0.086B | 0.00 |
Zynex (ZYXI) | United States | $0.076B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
Agape ATP (ATPC) | $0.070B | 0.00 | |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Nephros (NEPH) | United States | $0.043B | 58.29 |
Modular Medical (MODD) | United States | $0.040B | 0.00 |
Safety Shot (SHOT) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 13.10 |
Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.012B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |